Volunteers at risk

New England Journal of Medicine

Volumn 355, Issue 10, 2006, Pages 1060-1061

  Drazen, Jeffrey M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY TGN1412; UNCLASSIFIED DRUG;

ARTIFICIAL VENTILATION; CELL POPULATION; EDITORIAL; HUMAN; HYPOTENSION; INTENSIVE CARE; MULTIPLE ORGAN FAILURE; PERIPHERAL ISCHEMIA; PHYSIOLOGY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; T LYMPHOCYTE; VOLUNTEER;

ANTIBODIES, MONOCLONAL; CYTOKINES; HUMAN EXPERIMENTATION; HUMANS; MALE; MULTIPLE ORGAN FAILURE;

EID: 33748425448     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe068175     Document Type: Editorial

References (2)

1. Suntharalingam G, Perry MR, Ward S, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006;355:1018-28.
2. Sharpe AH, Abbas AK. T-cell costimulation - biology, therapeutic potential, and challenges. N Engl J Med 2006;355:973-5.